September 23 Product : UCBs Bimzelx Indication : Psoriatic arthritis, non-radiographic axial spondyloarthritis and ankylosing spondylitis UCBs Bimzelx was approved Monday for not one, but three chronic immune-mediated inflammatory diseases: psoriatic arthritis (PsA), non-radiographic axial spondyloarthritis (nr-axSpA) and ankylosing spondylitis (AS)
The accompanying recipe books ensured the impact would be sustainable, giving families resources to continue making healthy choices long after the events ended
Herati also cautioned that rapid weight loss, whether from GLP-1 drugs or bariatric surgery, can occasionally signal to the brain that conditions are not favorable for reproduction, potentially suppressing fertility temporarily
Hence, it increases the demand for GLP-1 drugs for their effective management
Probiotics and prebiotics offer excellent opportunities to create value-added products that can meet the needs of health-conscious consumers and GLP-1 users